FENNEC PHARMACEUTICALS INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Fennec Pharmaceuticals Inc. Return On Assets for the quarter ending June 30, 2024 was 6.11 %.
  • Fennec Pharmaceuticals Inc. annual Return On Assets for 2023 was -72.9 %, a 29.3% increase from 2022.
  • Fennec Pharmaceuticals Inc. annual Return On Assets for 2022 was -103 %, a 55% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Return On Assets for 2021 was -66.5 %, a 5.71% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -72.9 +30.2 +29.3% Jan 1, 2023 Dec 31, 2023
2022 -103 -36.5 -55% Jan 1, 2022 Dec 31, 2022
2021 -66.5 -3.59 -5.71% Jan 1, 2021 Dec 31, 2021
2020 -62.9 +11.7 +15.6% Jan 1, 2020 Dec 31, 2020
2019 -74.6 Jan 1, 2019 Dec 31, 2019
2017 -54.4 +24 +30.6% Jan 1, 2017 Dec 31, 2017
2016 -78.3 -36.4 -86.9% Jan 1, 2016 Dec 31, 2016
2015 -41.9 +117 +73.6% Jan 1, 2015 Dec 31, 2015
2014 -159 -296 -215% Jan 1, 2014 Dec 31, 2014
2013 138 +289 Jan 1, 2013 Dec 31, 2013
2012 -151 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.